Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non–Small-Cell Lung Cancer

Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC

(2021) Mengke Niu et al.   Experimental Hematology & Oncology

High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment

(2020) Lissete Sánchez-Magraner et al.   CANCER RESEARCH

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4

(2019) Shuang Qin et al.   Molecular Cancer

Predictive potential and need for standardization of PD-L1 immunohistochemistry

(2018) Spasenija Savic Prince et al.   VIRCHOWS ARCHIV

Trends and advances in tumor immunology and lung cancer immunotherapy

(2016) Mohanad Aldarouish et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

High-Throughput Time-Resolved FRET Reveals Akt/PKB Activation as a Poor Prognostic Marker in Breast Cancer

(2014) S. Veeriah et al.   CANCER RESEARCH

Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization

(2012) Jan Budczies et al.   PLoS One